Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids - PubMed (original) (raw)
Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids
Z Wu et al. Mol Cell Biol. 1996 Aug.
Abstract
The differentiation of 3T3 preadipocytes into adipocytes is accompanied by a transient induction of C/EBPbeta and C/EBPdelta expression in response to treatment of the cells with methylisobutylxanthine (MIX) and dexamethasone (DEX), respectively. In this report, we demonstrate that peroxisome proliferator-activated receptor gamma (PPARgamma) expression in 3T3-L1 preadipocytes is induced by MIX and DEX, suggesting that C/EBPbeta and C/EBPdelta may be involved in this process. Using a tetracycline-responsive expression system, we have recently shown that the conditional ectopic expression of C/EBPbeta in NIH 3T3 fibroblasts (beta2 cells) in the presence of DEX activates the synthesis of peroxisome PPARgamma mRNA. Subsequent exposure of these cells to PPAR activators stimulates their conversion into adipocytes; however, neither the expression of C/EBPbeta nor exposure to DEX alone is capable of inducing PPARgamma expression in the beta2 cell line. We find that unlike the case for 3T3 preadipocytes, C/EBPdelta is not induced by DEX in these 3T3 fibroblasts and therefore is not relaying the effect of this glucocorticoid to the PPARgamma gene. To define the role of glucocorticoids in regulating PPARgamma expression and the possible involvement of C/EBPdelta, we have established an additional set of NIH 3T3 cell lines expressing either C/EBPdelta alone (delta23 cells) or C/EBPdelta and C/EBPbeta together (beta/delta39 cells), using the tetracycline-responsive system. Culture of these cells in tetracycline-deficient medium containing DEX, MIX, insulin, and fetal bovine serum shows that the beta/delta39 cells express PPARgamma and aP2 mRNAs at levels that are almost equivalent to those observed in fully differentiated 3T3-L1 adipocytes. These levels are approximately threefold higher than their levels of expression in the beta2 cells. Despite the fact that these beta/delta39 cells produce abundant amounts of C/EBPbeta and C/EBPdelta (in the absence of tetracycline), they still require glucocorticoids to attain maximum expression of PPARgamma mRNA. Furthermore, the induction of PPARgamma mRNA by exposure of these cells to DEX occurs in the absence of ongoing protein synthesis. The delta23 cells, on the other hand, are not capable of activating PPARgamma gene expression when exposed to the same adipogenic inducers. Finally, attenuation of ectopic C/EBPbeta production at various stages during the differentiation process results in a concomitant inhibition of PPARgamma and the adipogenic program. These data strongly suggest that the induction of PPARgamma gene expression in multipotential mesenchymal stem cells (NIH 3T3 fibroblasts) is dependent on elevated levels of C/EBPbeta throughout the differentiation process, as well as an initial exposure to glucocorticoids. C/EBPdelta may function by synergizing with C/EBPbeta to enhance the level of PPARgamma expression.
Similar articles
- PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes.
Wu Z, Xie Y, Morrison RF, Bucher NL, Farmer SR. Wu Z, et al. J Clin Invest. 1998 Jan 1;101(1):22-32. doi: 10.1172/JCI1244. J Clin Invest. 1998. PMID: 9421462 Free PMC article. - Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis.
Wu Z, Xie Y, Bucher NL, Farmer SR. Wu Z, et al. Genes Dev. 1995 Oct 1;9(19):2350-63. doi: 10.1101/gad.9.19.2350. Genes Dev. 1995. PMID: 7557387 - A role for C/EBPbeta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes.
Hamm JK, Park BH, Farmer SR. Hamm JK, et al. J Biol Chem. 2001 May 25;276(21):18464-71. doi: 10.1074/jbc.M100797200. Epub 2001 Feb 27. J Biol Chem. 2001. PMID: 11279134 - PPARgamma-Dependent Control of Renin Expression: Molecular Mechanisms and Pathophysiological Relevance.
Todorov VT. Todorov VT. PPAR Res. 2013;2013:451016. doi: 10.1155/2013/451016. Epub 2013 Oct 30. PPAR Res. 2013. PMID: 24288524 Free PMC article. Review.
Cited by
- Current treatment paradigms and emerging therapies for NAFLD/NASH.
Raza S, Rajak S, Upadhyay A, Tewari A, Anthony Sinha R. Raza S, et al. Front Biosci (Landmark Ed). 2021 Jan 1;26(2):206-237. doi: 10.2741/4892. Front Biosci (Landmark Ed). 2021. PMID: 33049668 Free PMC article. Review. - Osteoblast-targeted overexpression of TAZ increases bone mass in vivo.
Yang JY, Cho SW, An JH, Jung JY, Kim SW, Kim SY, Kim JE, Shin CS. Yang JY, et al. PLoS One. 2013;8(2):e56585. doi: 10.1371/journal.pone.0056585. Epub 2013 Feb 18. PLoS One. 2013. PMID: 23441207 Free PMC article. - Mechanisms of glucocorticoid action in bone.
Canalis E. Canalis E. Curr Osteoporos Rep. 2005 Sep;3(3):98-102. doi: 10.1007/s11914-005-0017-7. Curr Osteoporos Rep. 2005. PMID: 16131429 Review. - Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives.
Altieri B, Muscogiuri G, Paschou SA, Vryonidou A, Della Casa S, Pontecorvi A, Fassnacht M, Ronchi CL, Newell-Price J. Altieri B, et al. Endocrine. 2018 Dec;62(3):506-516. doi: 10.1007/s12020-018-1696-z. Epub 2018 Aug 2. Endocrine. 2018. PMID: 30073456 Review.
References
- J Biol Chem. 1980 May 25;255(10):4745-50 - PubMed
- Cell. 1995 Dec 1;83(5):803-12 - PubMed
- Proc Natl Acad Sci U S A. 1984 Sep;81(17):5468-72 - PubMed
- Mol Pharmacol. 1987 Apr;31(4):377-84 - PubMed
- Anal Biochem. 1987 Apr;162(1):156-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials